Correlation Between Dogwood Therapeutics, and Psyence Biomedical
Can any of the company-specific risk be diversified away by investing in both Dogwood Therapeutics, and Psyence Biomedical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dogwood Therapeutics, and Psyence Biomedical into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dogwood Therapeutics, and Psyence Biomedical Ltd, you can compare the effects of market volatilities on Dogwood Therapeutics, and Psyence Biomedical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dogwood Therapeutics, with a short position of Psyence Biomedical. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dogwood Therapeutics, and Psyence Biomedical.
Diversification Opportunities for Dogwood Therapeutics, and Psyence Biomedical
0.61 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Dogwood and Psyence is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding Dogwood Therapeutics, and Psyence Biomedical Ltd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Psyence Biomedical and Dogwood Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dogwood Therapeutics, are associated (or correlated) with Psyence Biomedical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Psyence Biomedical has no effect on the direction of Dogwood Therapeutics, i.e., Dogwood Therapeutics, and Psyence Biomedical go up and down completely randomly.
Pair Corralation between Dogwood Therapeutics, and Psyence Biomedical
Given the investment horizon of 90 days Dogwood Therapeutics, is expected to under-perform the Psyence Biomedical. But the stock apears to be less risky and, when comparing its historical volatility, Dogwood Therapeutics, is 3.74 times less risky than Psyence Biomedical. The stock trades about -0.03 of its potential returns per unit of risk. The Psyence Biomedical Ltd is currently generating about 0.09 of returns per unit of risk over similar time horizon. If you would invest 2.75 in Psyence Biomedical Ltd on September 2, 2024 and sell it today you would lose (2.06) from holding Psyence Biomedical Ltd or give up 74.91% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 87.5% |
| Values | Daily Returns |
Dogwood Therapeutics, vs. Psyence Biomedical Ltd
Performance |
| Timeline |
| Dogwood Therapeutics, |
| Psyence Biomedical |
Dogwood Therapeutics, and Psyence Biomedical Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Dogwood Therapeutics, and Psyence Biomedical
The main advantage of trading using opposite Dogwood Therapeutics, and Psyence Biomedical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dogwood Therapeutics, position performs unexpectedly, Psyence Biomedical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Psyence Biomedical will offset losses from the drop in Psyence Biomedical's long position.| Dogwood Therapeutics, vs. Viracta Therapeutics | Dogwood Therapeutics, vs. Viking Therapeutics | Dogwood Therapeutics, vs. Dyadic International | Dogwood Therapeutics, vs. Surrozen Warrant |
| Psyence Biomedical vs. Viracta Therapeutics | Psyence Biomedical vs. Dogwood Therapeutics, | Psyence Biomedical vs. Viking Therapeutics | Psyence Biomedical vs. Dyadic International |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.
Other Complementary Tools
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |